Sanne de Bruin

168 Chapter 6 References 1. LutenM, Roerdinkholder-Stoelwinder B, Schaap NPM, De GripWJ, Bos HJ, Bosman GJCGM. Survival of red blood cells after transfusion: A comparison between red cells concentrates of different storage periods. Transfusion . 2008;48(7):1478-1485. doi:10.1111/j.1537-2995.2008.01734.x 2. Zeiler T, Müller JT, Kretschmer V. Flow-cytometric determination of survival time and 24-hour recovery of transfused red blood cells. Transfus Med Hemotherapy . 2003;30(1):14-19. doi:10.1159/000069340 3. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion . 2008;48(6):1053-1060. doi:10.1111/j.1537-2995.2008.01642.x 4. Howie HL, Hay AM, de Wolski K, et al. Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage inmice. Blood Adv . 2019;3(15):2272-2285. doi:10.1182/ bloodadvances.2019000605 5. Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents. Transfus Med . 2016;26(6):401-405. doi:10.1111/ tme.12380 6. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev . 2005;19(1):2-31. doi:10.1016/j.tmrv.2004.10.001 7. Frank SM, Abazyan B, Ono M, et al. Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg . 2013;116(5):975-981. doi:10.1213/ ANE.0b013e31828843e6 8. Lagerberg JW, Korsten H, Van Der Meer PF, De Korte D. Prevention of red cell storage lesion: a comparison of five different additive solutions. BloodTransfus . April 2017:1-7. doi:10.2450/2017.0371-16 9. Peters AL, Van Bruggen R, De Korte D, Van Noorden CJF, Vlaar APJ. Glucose-6-phosphate dehydrogenase activity decreases during storage of leukoreduced red blood cells. Transfusion . 2016;56(2):427-432. doi:10.1111/trf.13378 10. D’Alessandro A, Reisz JA, Culp-Hill R, Korsten H, van Bruggen R, de Korte D. Metabolic effect of alkaline additives and guanosine/gluconate in storage solutions for red blood cells. Transfusion . 2018;58(8):1992-2002. doi:10.1111/trf.14620 11. Yoshida T, Prudent M, D’Alessandro A. Red blood cell storage lesion: Causes and potential clinical consequences. Blood Transfus . 2019;17(1):27-52. doi:10.2450/2019.0217-18 12. NemkovT, Hansen KC, Dumont LJ, D’Alessandro A. Metabolomics in transfusionmedicine. Transfusion . 2016;56(4):980-993. doi:10.1111/trf.13442 13. Heaton A, Keegan T, Holme S. In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol . 1989;71(1):131-136. http:// www.ncbi.nlm.nih.gov/pubmed/2492818. 14. Matthes G, Strunk S, Siems W, Grune T. Posttransfusional changes of 2,3-diphosphoglycerate and nucleotides in CPD-SAGM-preserved erythrocytes. Infusionsther Transfusionsmed . 1993;20(3):89-92. http://www.ncbi.nlm.nih.gov/pubmed/8364333. 15. Scott A V., Nagababu E, Johnson DJ, et al. 2,3-Diphosphoglycerate Concentrations in Autologous Salvaged Versus Stored Red Blood Cells and in Surgical Patients after Transfusion. Anesth Analg . 2016;122(3):616-623. doi:10.1213/ANE.0000000000001071